Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

NASDAQ:MBLY - Nasdaq - US60741F1049 - Common Stock - Currency: USD

16.42  +1.7 (+11.55%)

After market: 16.58 +0.16 (+0.97%)

Fundamental Rating

4

Taking everything into account, MBLY scores 4 out of 10 in our fundamental rating. MBLY was compared to 81 industry peers in the Automobile Components industry. No worries on liquidiy or solvency for MBLY as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, MBLY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
MBLY had negative earnings in each of the past 5 years.
Each year in the past 5 years MBLY had a positive operating cash flow.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

MBLY's Return On Assets of -23.80% is on the low side compared to the rest of the industry. MBLY is outperformed by 90.12% of its industry peers.
MBLY's Return On Equity of -24.68% is on the low side compared to the rest of the industry. MBLY is outperformed by 83.95% of its industry peers.
Industry RankSector Rank
ROA -23.8%
ROE -24.68%
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

MBLY has a better Gross Margin (48.25%) than 98.77% of its industry peers.
MBLY's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MBLY has been increased compared to 1 year ago.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 15.84 indicates that MBLY is not in any danger for bankruptcy at the moment.
MBLY's Altman-Z score of 15.84 is amongst the best of the industry. MBLY outperforms 100.00% of its industry peers.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.84
ROIC/WACCN/A
WACC9.07%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

MBLY has a Current Ratio of 7.64. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 7.64, MBLY belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
MBLY has a Quick Ratio of 6.38. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
MBLY has a Quick ratio of 6.38. This is amongst the best in the industry. MBLY outperforms 96.30% of its industry peers.
Industry RankSector Rank
Current Ratio 7.64
Quick Ratio 6.38
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for MBLY have decreased strongly by -33.33% in the last year.
MBLY shows a decrease in Revenue. In the last year, the revenue decreased by -0.38%.
MBLY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.48% yearly.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%

3.2 Future

Based on estimates for the next years, MBLY will show a very strong growth in Earnings Per Share. The EPS will grow by 52.12% on average per year.
Based on estimates for the next years, MBLY will show a very strong growth in Revenue. The Revenue will grow by 23.58% on average per year.
EPS Next Y23.29%
EPS Next 2Y32.78%
EPS Next 3Y37.61%
EPS Next 5Y52.12%
Revenue Next Year7.32%
Revenue Next 2Y11.61%
Revenue Next 3Y15.53%
Revenue Next 5Y23.58%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 41.05, MBLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 74.07% of the companies listed in the same industry.
MBLY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.65.
A Price/Forward Earnings ratio of 37.25 indicates a quite expensive valuation of MBLY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 79.01% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.27. MBLY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 41.05
Fwd PE 37.25
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MBLY's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. MBLY is more expensive than 83.95% of the companies in the same industry.
MBLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MBLY is more expensive than 69.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.67
EV/EBITDA 103.37
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

MBLY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MBLY's earnings are expected to grow with 37.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.76
PEG (5Y)N/A
EPS Next 2Y32.78%
EPS Next 3Y37.61%

0

5. Dividend

5.1 Amount

MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (6/23/2025, 8:00:01 PM)

After market: 16.58 +0.16 (+0.97%)

16.42

+1.7 (+11.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners118.28%
Inst Owner Change10.17%
Ins Owners2.73%
Ins Owner Change-1.09%
Market Cap13.33B
Analysts74.12
Price Target19.7 (19.98%)
Short Float %22.36%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.88%
Min EPS beat(2)4.12%
Max EPS beat(2)15.64%
EPS beat(4)4
Avg EPS beat(4)9.55%
Min EPS beat(4)0.46%
Max EPS beat(4)17.98%
EPS beat(8)7
Avg EPS beat(8)11.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.39%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)0.55%
Revenue beat(4)3
Avg Revenue beat(4)0.53%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)1.6%
Revenue beat(8)4
Avg Revenue beat(8)-0.23%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.04%
PT rev (3m)-6.71%
EPS NQ rev (1m)1.68%
EPS NQ rev (3m)26.7%
EPS NY rev (1m)6.51%
EPS NY rev (3m)3.08%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)7.45%
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 41.05
Fwd PE 37.25
P/S 7.2
P/FCF 33.67
P/OCF 28.43
P/B 1.11
P/tB 5.67
EV/EBITDA 103.37
EPS(TTM)0.4
EY2.44%
EPS(NY)0.44
Fwd EY2.68%
FCF(TTM)0.49
FCFY2.97%
OCF(TTM)0.58
OCFY3.52%
SpS2.28
BVpS14.84
TBVpS2.9
PEG (NY)1.76
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.8%
ROE -24.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.25%
FCFM 21.37%
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 14.31%
Cap/Sales 3.94%
Interest Coverage N/A
Cash Conversion 464.36%
Profit Quality N/A
Current Ratio 7.64
Quick Ratio 6.38
Altman-Z 15.84
F-Score6
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
EPS Next Y23.29%
EPS Next 2Y32.78%
EPS Next 3Y37.61%
EPS Next 5Y52.12%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%
Revenue Next Year7.32%
Revenue Next 2Y11.61%
Revenue Next 3Y15.53%
Revenue Next 5Y23.58%
EBIT growth 1Y-115.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.67%
EBIT Next 3Y57.26%
EBIT Next 5Y48.26%
FCF growth 1Y7.77%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y1.52%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%